Search research articles
Contact Us
Filters
Showing results (261-270 of 401) with videos related to
Page
of 41
Sort By:
Journal of Cellular Physiology
|
November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways
Gang Wang, Kai Chen, Chao Ma, et al.
European Journal of Pharmacology
|
April 11, 2022
Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway
Liwei Wu, Jiamin Liang, Jing Li, et al.
The Journal of Biological Chemistry
|
January 12, 2023
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Heng Qiu, Christopher Hosking, Emel Rothzerg, et al.
Phytotherapy Research : PTR
|
August 23, 2021
Morin attenuates osteoclast formation and function by suppressing the NF-κB, MAPK and calcium signalling pathways
Yifeng Shi, Lin Ye, Shiwei Shen, et al.
Food & Function
|
September 25, 2019
Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways
Haiming Jin, Zhenxuan Shao, Qingqing Wang, et al.
Journal of Cellular Physiology
|
March 16, 2017
Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo
Cheng-Ming Wei, Qian Liu, Fang-Ming Song, et al.
Phytotherapy Research : PTR
|
August 4, 2024
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS
Jian Huang, Dezhi Song, Minglian Xu, et al.
Plos One
|
September 26, 2013
Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways
Xiaojuan Li, Longgang He, Yiping Hu, et al.
The American Journal of Pathology
|
May 31, 2012
Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation
Tristan J King, Kristen R Georgiou, Johanna C Cool, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 21, 2024
Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6
Xiaoliang Feng, Guining Wei, Yuangang Su, et al.
Page
of 41
Search research articles
Search
Showing results (261-270 of 401) with videos related to
Sort By:
Page
of 41
Journal of Cellular Physiology
|
November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways
Gang Wang, Kai Chen, Chao Ma, et al.
European Journal of Pharmacology
|
April 11, 2022
Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway
Liwei Wu, Jiamin Liang, Jing Li, et al.
The Journal of Biological Chemistry
|
January 12, 2023
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Heng Qiu, Christopher Hosking, Emel Rothzerg, et al.
Phytotherapy Research : PTR
|
August 23, 2021
Morin attenuates osteoclast formation and function by suppressing the NF-κB, MAPK and calcium signalling pathways
Yifeng Shi, Lin Ye, Shiwei Shen, et al.
Food & Function
|
September 25, 2019
Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways
Haiming Jin, Zhenxuan Shao, Qingqing Wang, et al.
Journal of Cellular Physiology
|
March 16, 2017
Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo
Cheng-Ming Wei, Qian Liu, Fang-Ming Song, et al.
Phytotherapy Research : PTR
|
August 4, 2024
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS
Jian Huang, Dezhi Song, Minglian Xu, et al.
Plos One
|
September 26, 2013
Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways
Xiaojuan Li, Longgang He, Yiping Hu, et al.
The American Journal of Pathology
|
May 31, 2012
Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation
Tristan J King, Kristen R Georgiou, Johanna C Cool, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 21, 2024
Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6
Xiaoliang Feng, Guining Wei, Yuangang Su, et al.
Page
of 41